UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 52

Sortiert nach

Drug Development Targeting the Ubiquitin-Proteasome System (UPS) for the Treatment of Human Cancers

Cancers, 2020, Vol.12 (4), p.902

2020

Volltextzugriff (PDF)

Deubiquitinating Enzymes in Coronaviruses and Possible Therapeutic Opportunities for COVID-19

International journal of molecular sciences, 2020-05, Vol.21 (10), p.3492

2020

Volltextzugriff (PDF)

Targeting Mitochondria for Treatment of Chemoresistant Ovarian Cancer

International journal of molecular sciences, 2019-01, Vol.20 (1), p.229

2019

Volltextzugriff (PDF)

The DNA Cytosine Deaminase APOBEC3B is a Molecular Determinant of Platinum Responsiveness in Clear Cell Ovarian Cancer

Clinical cancer research, 2020-07, Vol.26 (13), p.3397-3407

2020

Volltextzugriff (PDF)

Targeting Mitochondrial Metabolism in Clear Cell Carcinoma of the Ovaries

International journal of molecular sciences, 2021-04, Vol.22 (9), p.4750

2021

Volltextzugriff (PDF)

The Ovary-Brain Connection

Cells (Basel, Switzerland), 2024-01, Vol.13 (1), p.94

2024

Volltextzugriff (PDF)

Small-Molecule RA-9 Inhibits Proteasome-Associated DUBs and Ovarian Cancer In Vitro and In Vivo via Exacerbating Unfolded Protein Responses

Clinical cancer research, 2014-06, Vol.20 (12), p.3174-3186

2014

Volltextzugriff (PDF)

Abstract A41: Ovarian cancer as an infectious disease. Targeting of mitochondrial activity to prevent and treat recurrent ovarian cancer

Clinical cancer research, 2018-08, Vol.24 (15_Supplement), p.A41-A41

Bazzaro, Martina

2018

Volltextzugriff (PDF)

Combination of Proteasome and HDAC Inhibitors for Uterine Cervical Cancer Treatment

Clinical cancer research, 2009-01, Vol.15 (2), p.570-577

2009

Volltextzugriff (PDF)

Simultaneous inhibition of deubiquitinating enzymes (DUBs) and autophagy synergistically kills breast cancer cells

Oncotarget, 2015-02, Vol.6 (6), p.4159-4170

2015

Volltextzugriff (PDF)

USP14 is a predictor of recurrence in endometrial cancer and a molecular target for endometrial cancer treatment

Oncotarget, 2016-05, Vol.7 (21), p.30962-30976

2016

Volltextzugriff (PDF)

UNC-45A Is Highly Expressed in the Proliferative Cells of the Mouse Genital Tract and in the Microtubule-Rich Areas of the Mouse Nervous System

Cells (Basel, Switzerland), 2021-06, Vol.10 (7), p.1604

2021

Volltextzugriff (PDF)

Ubiquitin Proteasome System Stress Underlies Synergistic Killing of Ovarian Cancer Cells by Bortezomib and a Novel HDAC6 Inhibitor

Clinical cancer research, 2008-11, Vol.14 (22), p.7340-7347

2008

Volltextzugriff (PDF)

Cellular and Molecular Networking Within the Ecosystem of Cancer Cell Communication via Tunneling Nanotubes

Frontiers in cell and developmental biology, 2018-10, Vol.6, p.95-95

2018

Volltextzugriff (PDF)

Stressing the ubiquitin-proteasome system without 20S proteolytic inhibition selectively kills cervical cancer cells

PloS one, 2011-08, Vol.6 (8), p.e23888

2011

Volltextzugriff (PDF)

Ubiquitin-proteasome system stress sensitizes ovarian cancer to proteasome inhibitor-induced apoptosis

Cancer research (Chicago, Ill.), 2006-04, Vol.66 (7), p.3754-3763

2006

Volltextzugriff (PDF)

Establishment, characterization and downstream application of primary ovarian cancer cells derived from solid tumors

PloS one, 2012-11, Vol.7 (11), p.e50519-e50519

2012

Volltextzugriff (PDF)

Targeting Deubiquitinating Enzymes and Autophagy in Cancer

Methods in molecular biology (Clifton, N.J.), 2017-01, Vol.1513, p.49

2017

Volltextzugriff (PDF)

The microtubule-severing protein UNC-45A preferentially binds to curved microtubules and counteracts the microtubule-straightening effects of Taxol

The Journal of biological chemistry, 2023-11, Vol.299 (11), p.105355, Article 105355

2023

Volltextzugriff (PDF)

UNC-45A breaks the microtubule lattice independently of its effects on non-muscle myosin II

Journal of cell science, 2021-01, Vol.134 (1)

2021

Volltextzugriff (PDF)

Single cell sequencing reveals heterogeneity within ovarian cancer epithelium and cancer associated stromal cells

Gynecologic oncology, 2017-03, Vol.144 (3), p.598-606

2017

Volltextzugriff (PDF)

UNC-45A Breaks MT Lattice Independent of its Effect on Non-Muscle Myosin II

Journal of cell science, 2020-01

2020

Volltextzugriff (PDF)

UNC-45A Is a Novel Microtubule-Associated Protein and Regulator of Paclitaxel Sensitivity in Ovarian Cancer Cells

Molecular cancer research, 2019-02, Vol.17 (2), p.370-383

2019

Volltextzugriff (PDF)

UNC-45A is preferentially expressed in epithelial cells and binds to and co-localizes with interphase MTs

Cancer biology & therapy, 2019-10, Vol.20 (10), p.1304-1313

2019

Volltextzugriff (PDF)

UNC-45A Is a Nonmuscle Myosin IIA Chaperone Required for NK Cell Cytotoxicity via Control of Lytic Granule Secretion

The Journal of immunology (1950), 2015-11, Vol.195 (10), p.4760-4770

2015

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Aktive Filter

PublikationsformArtikel

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(49)

Sprache

Englisch
(52)
Japanisch
(10)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Drug Development Targeting the Ubiquitin-Proteasome System (UPS) for the Treatment of Human Cancers

Deubiquitinating Enzymes in Coronaviruses and Possible Therapeutic Opportunities for COVID-19

Targeting Mitochondria for Treatment of Chemoresistant Ovarian Cancer

The DNA Cytosine Deaminase APOBEC3B is a Molecular Determinant of Platinum Responsiveness in Clear Cell Ovarian Cancer

Targeting Mitochondrial Metabolism in Clear Cell Carcinoma of the Ovaries

The Ovary-Brain Connection

Small-Molecule RA-9 Inhibits Proteasome-Associated DUBs and Ovarian Cancer In Vitro and In Vivo via Exacerbating Unfolded Protein Responses

Abstract A41: Ovarian cancer as an infectious disease. Targeting of mitochondrial activity to prevent and treat recurrent ovarian cancer

Combination of Proteasome and HDAC Inhibitors for Uterine Cervical Cancer Treatment

Simultaneous inhibition of deubiquitinating enzymes (DUBs) and autophagy synergistically kills breast cancer cells

USP14 is a predictor of recurrence in endometrial cancer and a molecular target for endometrial cancer treatment

UNC-45A Is Highly Expressed in the Proliferative Cells of the Mouse Genital Tract and in the Microtubule-Rich Areas of the Mouse Nervous System

Ubiquitin Proteasome System Stress Underlies Synergistic Killing of Ovarian Cancer Cells by Bortezomib and a Novel HDAC6 Inhibitor

Cellular and Molecular Networking Within the Ecosystem of Cancer Cell Communication via Tunneling Nanotubes

Stressing the ubiquitin-proteasome system without 20S proteolytic inhibition selectively kills cervical cancer cells

Ubiquitin-proteasome system stress sensitizes ovarian cancer to proteasome inhibitor-induced apoptosis

Establishment, characterization and downstream application of primary ovarian cancer cells derived from solid tumors

Targeting Deubiquitinating Enzymes and Autophagy in Cancer

The microtubule-severing protein UNC-45A preferentially binds to curved microtubules and counteracts the microtubule-straightening effects of Taxol

UNC-45A breaks the microtubule lattice independently of its effects on non-muscle myosin II

Single cell sequencing reveals heterogeneity within ovarian cancer epithelium and cancer associated stromal cells

UNC-45A Breaks MT Lattice Independent of its Effect on Non-Muscle Myosin II

UNC-45A Is a Novel Microtubule-Associated Protein and Regulator of Paclitaxel Sensitivity in Ovarian Cancer Cells

UNC-45A is preferentially expressed in epithelial cells and binds to and co-localizes with interphase MTs

UNC-45A Is a Nonmuscle Myosin IIA Chaperone Required for NK Cell Cytotoxicity via Control of Lytic Granule Secretion

Aktive Filter

Suchergebnisse filtern